CA1319105C - Formulations antifongigues sous forme de gel - Google Patents

Formulations antifongigues sous forme de gel

Info

Publication number
CA1319105C
CA1319105C CA000594011A CA594011A CA1319105C CA 1319105 C CA1319105 C CA 1319105C CA 000594011 A CA000594011 A CA 000594011A CA 594011 A CA594011 A CA 594011A CA 1319105 C CA1319105 C CA 1319105C
Authority
CA
Canada
Prior art keywords
weight
gel formulation
ppg
imidazole
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000594011A
Other languages
English (en)
Inventor
Stacley Au
Hemanshu Shah
Jonas Wang
Bhiku Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/323,727 external-priority patent/US5002938A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of CA1319105C publication Critical patent/CA1319105C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000594011A 1988-03-21 1989-03-17 Formulations antifongigues sous forme de gel Expired - Fee Related CA1319105C (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US17135088A 1988-03-21 1988-03-21
US171,350 1988-03-21
US31805989A 1989-03-07 1989-03-07
US07/323,727 US5002938A (en) 1988-03-21 1989-03-15 Antifungal gel formulations
US323,727 1989-03-15
US318,059 1994-10-04

Publications (1)

Publication Number Publication Date
CA1319105C true CA1319105C (fr) 1993-06-15

Family

ID=27389963

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000594011A Expired - Fee Related CA1319105C (fr) 1988-03-21 1989-03-17 Formulations antifongigues sous forme de gel

Country Status (1)

Country Link
CA (1) CA1319105C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023245291A1 (fr) * 2022-06-22 2023-12-28 Scotiaderm Inc. Compositions pour la prévention et le traitement de lésions cutanées associées à l'humidité

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023245291A1 (fr) * 2022-06-22 2023-12-28 Scotiaderm Inc. Compositions pour la prévention et le traitement de lésions cutanées associées à l'humidité

Similar Documents

Publication Publication Date Title
US5002938A (en) Antifungal gel formulations
US5110809A (en) Antifungal gel formulations
US8232304B2 (en) Antifungal formulations
US5219877A (en) Lauryl alcohol as skin penetration enhancer for topical imidazole agents
US5422361A (en) Stable cream and lotion bases for lipophilic drug compositions
EP1759702B1 (fr) Procédé de préparation d'une solution ophtalmique de latanoprost et solution ainsi obtenue
RU2325912C1 (ru) Фармацевтическая композиция противовоспалительного и антимикробного действия в форме мази на гидрофобной основе для лечения кожных заболеваний (варианты)
US5208015A (en) Topical anti-fungal agents having anti-inflammatory activity
CA1049409A (fr) Preparation a usage local contenant un steroide et de la neomycine
US4489071A (en) Betamethasone dipropionate cream
CA1319105C (fr) Formulations antifongigues sous forme de gel
US5817675A (en) Compositions for the treatment of psoriasis and their use
NZ235054A (en) Gel formulation comprising imidazole antifungal agent and a 17-ester steroid anti-inflammatory agent with a co-solvent system and a gelling agent
EP0325949B1 (fr) Solutions concentrées de corticostéroides et leurs procédés de préparation
KR930000050B1 (ko) 항균제 겔 배합물
US5879711A (en) Stable antiandrogenic gel composition
JPH09176014A (ja) 抗真菌性外用組成物
KR950000032B1 (ko) 질산 에코나졸과 트리암시놀론 아세토니드의 혼합액제
PT95175A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um imidazol e um corticosteroide sob a forma de um gel para administracao topica com accao antifungica
GB2279567A (en) Topical 8-hydroxyquinoline compositions
CA1231052A (fr) Vehicule utilisable dans les preparations medicinales
DD297555A5 (de) Antimykotische gelformulierungen
EP2172202A1 (fr) Agent liquide aqueux contenant un dérivé de prostaglandine

Legal Events

Date Code Title Description
MKLA Lapsed